ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Leap Therapeutics Inc

Leap Therapeutics Inc (LPTX)

3.08
-0.02
( -0.65% )
Updated: 11:26:21

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
3.08
Bid
3.08
Ask
3.12
Volume
81,925
3.05 Day's Range 3.23
1.68 52 Week Range 4.79
Market Cap
Previous Close
3.10
Open
3.12
Last Trade
6
@
3.095
Last Trade Time
11:25:51
Financial Volume
$ 257,251
VWAP
3.1401
Average Volume (3m)
395,354
Shares Outstanding
38,317,897
Dividend Yield
-
PE Ratio
-1.45
Earnings Per Share (EPS)
-2.12
Revenue
-
Net Profit
-81.41M

About Leap Therapeutics Inc

Leap Therapeutics Inc is a biopharmaceutical company developing novel therapies designed to treat patients with cancer by inhibiting fundamental tumor-promoting pathways and by harnessing the immune system to attack cancer cells. Its clinical stage program is DKN-01, a monoclonal antibody that inhib... Leap Therapeutics Inc is a biopharmaceutical company developing novel therapies designed to treat patients with cancer by inhibiting fundamental tumor-promoting pathways and by harnessing the immune system to attack cancer cells. Its clinical stage program is DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1, or DKK1. DKK1 is a protein that regulates the Wnt signaling pathways and enables tumor cells to proliferate and spread, as well as suppresses the immune system from attacking the tumor. The company is studying DKN-01 in multiple ongoing clinical trials in patients with esophagogastric cancer, hepatobiliary cancer, gynecologic cancers, or prostate cancer. Its other clinical studies include P100, P102, P204,and P205. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
Headquarters
Wilmington, Delaware, USA
Founded
-
Leap Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker LPTX. The last closing price for Leap Therapeutics was $3.10. Over the last year, Leap Therapeutics shares have traded in a share price range of $ 1.68 to $ 4.79.

Leap Therapeutics currently has 38,317,897 shares outstanding. The market capitalization of Leap Therapeutics is $118.79 million. Leap Therapeutics has a price to earnings ratio (PE ratio) of -1.45.

LPTX Latest News

Leap Therapeutics to Participate at the 43rd Annual J.P. Morgan Healthcare Conference

Leap Therapeutics to Participate at the 43rd Annual J.P. Morgan Healthcare Conference PR Newswire CAMBRIDGE, Mass., Jan. 6, 2025 CAMBRIDGE, Mass., Jan. 6, 2025 /PRNewswire/ -- Leap Therapeutics...

Leap Therapeutics to Participate at Piper Sandler 36th Annual Healthcare Conference

Leap Therapeutics to Participate at Piper Sandler 36th Annual Healthcare Conference PR Newswire CAMBRIDGE, Mass., Nov. 26, 2024 CAMBRIDGE, Mass., Nov. 26, 2024 /PRNewswire/ -- Leap Therapeutics...

Leap Therapeutics Reports Third Quarter 2024 Financial Results

Leap Therapeutics Reports Third Quarter 2024 Financial Results PR Newswire CAMBRIDGE, Mass., Nov. 13, 2024 CAMBRIDGE, Mass., Nov. 13, 2024 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.28-8.333333333333.363.582.882721613.21354177CS
40.093.010033444822.993.582.722641583.09570083CS
120.13.355704697992.984.792.473953543.24277827CS
260.7331.06382978722.354.791.92554193.04464966CS
52-0.56-15.38461538463.644.791.682549282.94614011CS
156-24.52-88.840579710127.631.11.2355420819.33579374CS
260-13.92-81.88235294121741.71.23590470519.32644797CS

LPTX - Frequently Asked Questions (FAQ)

What is the current Leap Therapeutics share price?
The current share price of Leap Therapeutics is $ 3.08
How many Leap Therapeutics shares are in issue?
Leap Therapeutics has 38,317,897 shares in issue
What is the market cap of Leap Therapeutics?
The market capitalisation of Leap Therapeutics is USD 118.79M
What is the 1 year trading range for Leap Therapeutics share price?
Leap Therapeutics has traded in the range of $ 1.68 to $ 4.79 during the past year
What is the PE ratio of Leap Therapeutics?
The price to earnings ratio of Leap Therapeutics is -1.45
What is the reporting currency for Leap Therapeutics?
Leap Therapeutics reports financial results in USD
What is the latest annual profit for Leap Therapeutics?
The latest annual profit of Leap Therapeutics is USD -81.41M
What is the registered address of Leap Therapeutics?
The registered address for Leap Therapeutics is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the Leap Therapeutics website address?
The website address for Leap Therapeutics is www.leaptx.com
Which industry sector does Leap Therapeutics operate in?
Leap Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
ERNAEterna Therapeutics Inc
$ 0.801938
(159.53%)
441.13M
NMHINatures Miracle Holding Inc
$ 2.4242
(114.53%)
141.01M
HEESH and E Equipment Services Inc
$ 90.24
(105.37%)
7.99M
AIFFFirefly Neuroscience Inc
$ 3.6005
(89.50%)
106.9M
XXII22nd Century Group Inc
$ 9.34
(55.67%)
6.25M
PHIOPhio Pharmaceuticals Corporation
$ 3.618
(-45.18%)
8.12M
MBIOMustang Bio Inc
$ 0.1415
(-36.80%)
10.96M
SLRXSalarius Pharmaceuticals Inc
$ 2.57
(-29.97%)
1.32M
ATPCAgape ATP Corporation
$ 1.42
(-27.92%)
859.31k
AVGRAvinger Inc
$ 0.5875
(-26.85%)
1.03M
ERNAEterna Therapeutics Inc
$ 0.8001
(158.93%)
441.2M
RGTIRigetti Computing Inc
$ 6.8702
(13.56%)
153.32M
NMHINatures Miracle Holding Inc
$ 2.4299
(115.04%)
141.02M
AIFFFirefly Neuroscience Inc
$ 3.6001
(89.48%)
106.91M
NVDANVIDIA Corporation
$ 131.22
(-1.51%)
91.61M

LPTX Discussion

View Posts
ANTADOG ANTADOG 1 day ago
nice volume comin' in, 3,22~~, ANT
👍️0
ANTADOG ANTADOG 6 days ago
added some more, only partial fill, ANT
👍️0
ANTADOG ANTADOG 1 week ago
nice chart setup, solid 3,50 break gettin' closer, ANT
👍️0
ANTADOG ANTADOG 2 weeks ago
4's towards nxt update and jp conference almost a given, ANT
👍️0
ANTADOG ANTADOG 2 weeks ago
touchin' 3's again, so little vol needed, nxt update should be saweet imvho ANT
👍️0
ANTADOG ANTADOG 3 weeks ago
touched 3 again, small prelude of things to come, imosho ANT
👍️0
ANTADOG ANTADOG 4 weeks ago
hearin' some good things comin' our way, hmm, u got to pay to play, ANT
👍️0
ANTADOG ANTADOG 1 month ago
Added 2,96~~ ANT
👍️0
ANTADOG ANTADOG 1 month ago
3,40~~ because they know... ANT
👍️0
ANTADOG ANTADOG 1 month ago
accumulated a nice amount around 3 bucks, longterm, ANT
👍️0
ANTADOG ANTADOG 1 month ago
3,35~~ ANT
👍️0
ANTADOG ANTADOG 1 month ago
3,33~~ ANT
👍️0
ANTADOG ANTADOG 1 month ago
Volume intact, ANT
👍️0
ANTADOG ANTADOG 1 month ago
hooverin' above 3 bucks, ceo certainly gave them somethin' to think about, to be continued.... ANT
👍️0
ANTADOG ANTADOG 1 month ago
3,33~~ ANT
👍️0
ANTADOG ANTADOG 1 month ago
3,24~~ ANT
👍️0
ANTADOG ANTADOG 1 month ago
3,19~~ ANT
👍️0
ANTADOG ANTADOG 1 month ago
mm in trouble lol, ANT
👍️0
ANTADOG ANTADOG 1 month ago
3,12~~ ANT
👍️0
ANTADOG ANTADOG 1 month ago
3,10 break is close, hmm, ANT
👍️0
ANTADOG ANTADOG 1 month ago
added some 2,80's, likin' the chart, ANT
👍️0
glenn1919 glenn1919 1 month ago
LPTX..........................https://stockcharts.com/h-sc/ui?s=LPTX&p=W&b=5&g=0&id=p86431144783
👍️0
ANTADOG ANTADOG 2 months ago
And some more 3,25's longterm, ANT
👍️0
ANTADOG ANTADOG 2 months ago
added 3,70 ANT
👍️0
ANTADOG ANTADOG 2 months ago
held first support, startin' to like this one more and more, gild support, fyi ANT
👍️0
ANTADOG ANTADOG 2 months ago
added first support, ANT
👍️0
ANTADOG ANTADOG 3 months ago
consistent buyin' often means deeper pockets like what they see or are about to find out, so they add while it's cheap, imo but we'll see soon, ANT
👍️0
ANTADOG ANTADOG 3 months ago
puppy's goin' for a new 52wk high imo ANT
👍️0
ANTADOG ANTADOG 3 months ago
because it's a double digitland stock, xcellent results will propel it imosho ANT
👍️0
joelawyer joelawyer 3 months ago
Any clue what's driving this major upside move the last week?

👍️0
glenn1919 glenn1919 3 months ago
LPTX..........................https://stockcharts.com/h-sc/ui?s=LPTX&p=W&b=5&g=0&id=p86431144783
👍️0
glenn1919 glenn1919 3 months ago
LPTX..........................https://stockcharts.com/h-sc/ui?s=LPTX&p=W&b=5&g=0&id=p86431144783
👍️0
Monksdream Monksdream 4 months ago
LPTX under $3
👍️0
Monksdream Monksdream 6 months ago
LPTX under $3
👍️0
Monksdream Monksdream 6 months ago
LPTX under $2
👍️0
Monksdream Monksdream 8 months ago
LPTX under $5
👍️0
glenn1919 glenn1919 9 months ago
LPTX...................................https://stockcharts.com/h-sc/ui?s=LPTX&p=W&b=5&g=0&id=p86431144783
👍️0
Monksdream Monksdream 10 months ago
LPTX 10Q due March 12
👍️0
glenn1919 glenn1919 1 year ago
LPTX.......................................https://stockcharts.com/h-sc/ui?s=LPTX&p=W&b=5&g=0&id=p86431144783
👍️0
glenn1919 glenn1919 1 year ago
LPTX................................https://stockcharts.com/h-sc/ui?s=LPTX&p=W&b=5&g=0&id=p86431144783
👍️0
Monksdream Monksdream 1 year ago
LPTX new 52 week low
👍️0
Monksdream Monksdream 1 year ago
LPTX new 52 week low
👍️0
Slicky1315 Slicky1315 2 years ago
Wow..almost a year and no one posted anything!!
👍️0
VivaLasVegas VivaLasVegas 3 years ago
No one in their right mind gives 2 Sheets what some joke analyst gives for any price target

They are Shills
👍️0
stockguard stockguard 3 years ago
LPTX Piper ups Leap Therapeutics target to $6 following DKN-01's ASCO GI Update Jan. 23
Piper Sandler analyst Joseph Catanzaro raised the firm's price target on Leap Therapeutics (LPTX) to $6 from $5 and keeps an Overweight rating on the shares. Following the ASCO GI update for DKN-01, Leap hosted a conference call on Friday to walk through the data and lay out potential next steps, the analyst notes. When considering potential treatment effect, Catanzaro thinks the signal in DKK1-high patients looks even more compelling. Leap believes it could initiate a small randomized Phase II as part of the current IND that could generate data in 2023, while simultaneously engaging regulatory agencies on registrational strategies. Most notably, BeiGene's (BGNE) opt-in decision for Asian rights will almost certainly be a 2022 event, and the analyst continues to believe the ASCO GI update should make that a straightforward choice.
👍️0
Deano361 Deano361 3 years ago
yep, something big happening here.
👍️0
crudeoil24 crudeoil24 3 years ago
4.08 > hod.
👍️0
masterofdisaster masterofdisaster 3 years ago
I think I am going to double my position on Monday
👍️0
Deano361 Deano361 3 years ago
Yeah that was super strong after share offer . I think Beigene (sp?) may know this is real and we are a $10 acquisition target next year
👍️0
masterofdisaster masterofdisaster 3 years ago
The daily build up of short exempts on this momentum is driving the move. The cancer treatment results started the move. We shook off the share dump like it was nothing
👍️0

Your Recent History

Delayed Upgrade Clock